Indegene Ltd, originally established in 1998 as Indegene Lifesystems Private Limited, is a digital-first commercialization company focused on the global life sciences industry. The company, headquartered in Mumbai, transitioned to a public entity in 2022. Indegene offers a comprehensive suite of solutions for biopharmaceutical, biotech, and medical device companies, covering commercial, medical, regulatory, and R&D operations. Their Enterprise Commercial Solutions (ECS) enhance digital marketing, while Omnichannel Activation solutions optimize product promotion across multiple channels. The company also provides Enterprise Medical and Clinical Solutions, focusing on regulatory operations and improving efficiencies in drug discovery and clinical trials through data management and analytics.
Indegene has expanded its strategic capabilities through various acquisitions, including Encima Group and Cult Health. The company recently demerged its commercial software business and plans to raise Rs 950 crores through public offerings. These strategic moves aim to bolster its position in the life sciences sector, offering enhanced digital transformation and commercialization services.
